Osama Mohamad, M.D., Ph.D.

Peer-Reviewed Articles

1. Lichter KE, Charbonneau K, Lewy JR, Bloom JR, Shenker R, Sabbagh A, Chino J, Rodrigues A, Hearn J, Grover S, Sheu RD, Witztum A, Qureshi MM, Yom SS, Anand C, Thiel CL, Mohamad O. Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation. Lancet Oncol 25(6):790-801, 2024. PMID: 38821084.
2. Roy S, Saad F, Malone S, Agarwal N, Mohamad O, Morgan SC, Malone J, Swami U, Jia AY, Gebrael G, Mendiratta P, Brown JR, Rao SK, Sun Y, Wallis CJD, Chi KN, Chowdhury S, Kishan AU, Spratt DE. Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study. Eur Urol 85(4):398-400, 2024. PMID: 38485300.
3. Shelan M, Achard V, Appiagyei F, Mose L, Zilli T, Fankhauser CD, Zamboglou C, Mohamad O, Aebersold DM, Cathomas R. Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate Cancer Prostatic Dis. e-Pub 2024. PMID: 38589645.
4. Shaheen H, Salans MA, Mohamad O, Coleman PW, Ahmed S, Roach M. Age 70 +/- 5 Years and Cancer Specific Outcomes after Treatment of Localized Prostate Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys 118(3):672-681, 2024. e-Pub 2023. PMID: 37788716.
5. Mohamad O, Zamboglou C, Zilli T, Murthy V, Aebersold DM, Loblaw A, Guckenberger M, Shelan M. Safety of Ultrahypofractionated Pelvic Nodal Irradiation in the Definitive Management of Prostate Cancer: Systematic Review and Meta-analysis. Int J Radiat Oncol Biol Phys 118(4):998-1010, 2024. e-Pub 2023. PMID: 37863241.
6. Silverwood S, Lichter K, Conway A, Drew T, McComas KN, Zhang S, Gopakumar GM, Abdulbaki H, Smolen KA, Mohamad O, Grover S. Distance Traveled by Patients Globally to Access Radiotherapy: A Systematic Review. Int J Radiat Oncol Biol Phys 118(4):891-899, 2024. e-Pub 2023. PMID: 37949324.
7. Lichter KE, Baniel CC, Do I, Medhat Y, Avula V, Nogueira LM, Bates JE, Paulsson A, Malik N, Hiatt RA, Yom SS, Mohamad O. Effects of Wildfire Events on California Radiation Oncology Clinics and Patients. Adv Radiat Oncol 9(3):101395, 2024. e-Pub 2023. PMID: 38304108.
8. Lichter KE, Sabbagh A, Demeulenaere S, Drew T, Conway A, Nogueira L, Suneja G, Kirkwood K, Hampshire K, Gundling K, Teherani A, Thottathil SE, Mohamad O. Reducing the Environmental Impact of Health Care Conferences: A Study of Emissions and Practical Solutions. JCO Glob Oncol 10:e2300209, 2024. PMID: 38359373.
9. Thomas H, Chen JJ, Shaheen H, Sabbagh A, Abdul-Baki H, Chau OW, Malik N, Ayoub A, Hassanzadeh C, Hsu IC, Mohamad O. Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series. J Contemp Brachytherapy 16(1):1-5, 2024. e-Pub 2024. PMID: 38584887.
10. Sabbagh A, Tilki D, Feng J, Huland H, Graefen M, Wiegel T, Böhmer D, Hong JC, Valdes G, Cowan JE, Cooperberg M, Feng FY, Mohammad T, Shelan M, D'Amico AV, Carroll PR, Mohamad O. Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy. Eur Urol Focus 10(1):66-74, 2024. e-Pub 2023. PMID: 37507248.
11. Thomas H, Chen JJ, Abdul-Baki H, Sabbagh A, Shaheen H, Chau OW, Malik N, Ayoub A, Hassanzadeh C, Hsu IC, Mohamad O. Safety of high-dose rate (HDR) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series. Brachytherapy 23(2):173-178, 2024. e-Pub 2023. PMID: 38160102.
12. Ross AE, Zhang J, Huang HC, Yamashita R, Keim-Malpass J, Simko JP, DeVries S, Morgan TM, Souhami L, Dobelbower MC, McGinnis LS, Jones CU, Dess RT, Zeitzer KL, Choi K, Hartford AC, Michalski JM, Raben A, Gomella LG, Sartor AO, Rosenthal SA, Sandler HM, Spratt DE, Pugh SL, Mohamad O, Esteva A, Chen E, Schaeffer EM, Tran PT, Feng FY. External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial. Eur Urol Oncol. e-Pub 2024. PMID: 38302323.
13. Mohamad O, Nicosia L, Mathier E, Riggenbach E, Zamboglou C, Aebersold DM, Alongi F, Shelan M. Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis. Brachytherapy 23(3):309-320, 2024. e-Pub 2024. PMID: 38431441.
14. Sabol RA, Patel AM, Sabbagh A, Wilson C, Yuen F, Lindenfeld P, Aggarwal R, Breyer B, Mohamad O. A case of cetuximab-induced radiation recall skin dermatitis and review of the literature. Radiat Oncol J 41(4):292-296, 2023. e-Pub 2023. PMID: 38185934.
15. Lichter KE, Charbonneau K, Sabbagh A, Witztum A, Chuter R, Anand C, Thiel CL, Mohamad O. Evaluating the Environmental Impact of Radiation Therapy Using Life Cycle Assessments: A Critical Review. Int J Radiat Oncol Biol Phys 117(3):554-567, 2023. e-Pub 2023. PMID: 37172916.
16. Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR. Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer. Urol Oncol 41(10):429.e9-429.e14, 2023. e-Pub 2023. PMID: 37407420.
17. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol 6(5):501-507, 2023. e-Pub 2023. PMID: 36868922.
18. Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR. The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer. Urology 178:114-119, 2023. e-Pub 2023. PMID: 37244430.
19. Sadighian M, Hakam N, Amend G, Shaw NM, Tahir P, Allen IE, Nabavizadeh B, Holler J, Shibley W, Li KD, Abbasi B, Bell A, Mohamad O, Breyer BN. Radiation-induced Fistulas in Patients With Prior Pelvic Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis. Urology 176:121-126, 2023. e-Pub 2023. PMID: 36963666.
20. Sabbagh A, Weiss J, Tawk B, Mohammed MA, Abdulbaki H, Moraes FY, Grover S, Yap ML, Zubizarreta E, Lievens Y, Rodin D, Mohamad O. Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey. JCO Glob Oncol 9:e2300046, 2023. PMID: 37319396.
21. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Mohamad O, Cowan JE, Feng FY, Carroll PR, D'Amico AV. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 41(13):2428-2435, 2023. e-Pub 2023. PMID: 36857638.
22. Spratt DE, Tang S, Sun Y, Huang HC, Chen E, Mohamad O, Armstrong AJ, Tward JD, Nguyen PL, Lang JM, Zhang J, Mitani A, Simko JP, DeVries S, van der Wal D, Pinckaers H, Monson JM, Campbell HA, Wallace J, Ferguson MJ, Bahary JP, Schaeffer EM, NRG Prostate Cancer AI Consortium, Sandler HM, Tran PT, Rodgers JP, Esteva A, Yamashita R, Feng FY. Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer. Res Sq, 2023. e-Pub 2023. PMID: 37131691.
23. Kwon DH, Shakhnazaryan N, Shui D, Hong JC, Mohamad O, de Kouchkovsky I, Borno HT, Bose R, Chou J, Desai A, Fong L, Friedlander TW, Koshkin VS, Aggarwal RR, Feng FY, Hope TA, Small EJ. Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urol Oncol 41(3):145.e7-145.e15, 2023. e-Pub 2022. PMID: 36435709.
24. Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE, NRG Prostate Cancer AI Consortium, Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O. Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit Med 6(1):27, 2023. e-Pub 2023. PMID: 36813827.
25. Mushonga M, Weiss J, Liu ZA, Nyakabau AM, Mohamad O, Tawk B, Moraes FY, Grover S, Yap ML, Zubizarreta E, Lievens Y, Rodin D. Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO Glob Oncol 9:e2200127, 2023. PMID: 36706350.
26. Ni L, Chen K, Phuong C, Sabbagh AR, Wong AC, Mohamad O, Hsu IC. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy. Brachytherapy 22(3):304-309, 2023. e-Pub 2023. PMID: 36623988.
27. Sabbagh A, Mohamad O, Lichter KE, Hope TA. Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET. Cancers (Basel) 14(24), 2022. e-Pub 2022. PMID: 36551678.
28. Haeuser E, Serfes AL, Cork MA, Yang M, Abbastabar H, Abhilash ES, Adabi M, Adebayo OM, Adekanmbi V, Adeyinka DA, Afzal S, Ahinkorah BO, Ahmadi K, Ahmed MB, Akalu Y, Akinyemi RO, Akunna CJ, Alahdab F, Alanezi FM, Alanzi TM, Alene KA, Alhassan RK, Alipour V, Almasi-Hashiani A, Alvis-Guzman N, Ameyaw EK, Amini S, Amugsi DA, Ancuceanu R, Anvari D, Appiah SCY, Arabloo J, Aremu O, Asemahagn MA, Jafarabadi MA, Awedew AF, Quintanilla BPA, Ayanore MA, Aynalem YA, Azari S, Azene ZN, Darshan BB, Babalola TK, Baig AA, Banach M, Bärnighausen TW, Bell AW, Bhagavathula AS, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bijani A, Bitew ZW, Bohlouli S, Bolarinwa OA, Boloor A, Bozicevic I, Butt ZA, Cárdenas R, Carvalho F, Charan J, Chattu VK, Chowdhury MAK, Chu DT, Cowden RG, Dahlawi SMA, Damiani G, Darteh EKM, Darwesh AM, das Neves J, Weaver ND, De Leo D, De Neve JW, Deribe K, Deuba K, Dharmaratne S, Dianatinasab M, Diaz D, Didarloo A, Djalalinia S, Dorostkar F, Dubljanin E, Duko B, El Tantawi M, El-Jaafary SI, Eshrati B, Eskandarieh S, Eyawo O, Ezeonwumelu IJ, Ezzikouri S, Farzadfar F, Fattahi N, Fauk NK, Fernandes E, Filip I, Fischer F, Foigt NA, Foroutan M, Fukumoto T, Gad MM, Gaidhane AM, Gebregiorgis BG, Gebremedhin KB, Getacher L, Ghadiri K, Ghashghaee A, Golechha M, Gubari MIM, Gugnani HC, Guimarães RA, Haider MR, Haj-Mirzaian A, Hamidi S, Hashi A, Hassanipour S, Hassankhani H, Hayat K, Herteliu C, Ho HC, Holla R, Hosseini M, Hosseinzadeh M, Hwang BF, Ibitoye SE, Ilesanmi OS, Ilic IM, Ilic MD, Islam RM, Iwu CCD, Jakovljevic M, Jha RP, Ji JS, Johnson KB, Joseph N, Joshua V, Joukar F, Jozwiak JJ, Kalankesh LR, Kalhor R, Kamyari N, Kanchan T, Matin BK, Karimi SE, Kayode GA, Karyani AK, Keramati M, Khan EA, Khan G, Khan MN, Khatab K, Khubchandani J, Kim YJ, Kisa A, Kisa S, Kopec JA, Kosen S, Laxminarayana SLK, Koyanagi A, Krishan K, Defo BK, Kugbey N, Kulkarni V, Kumar M, Kumar N, Kusuma D, La Vecchia C, Lal DK, Landires I, Larson HJ, Lasrado S, Lee PH, Li S, Liu X, Maleki A, Malik P,. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018. BMC Med 20(1):488, 2022. e-Pub 2022. PMID: 36529768.
29. Lichter KE, Drew T, Demeulenaere S, Wong E, Mohamad O, Yom SS, Bagshaw HP. Environmental Outcomes Associated With Transition From In-Person to a Virtual Oncology Conference During the COVID-19 Pandemic. JAMA Oncol 8(9):1351-1352, 2022. PMID: 35737362.
30. Lichter KE, Anderson J, Sim AJ, Baniel CC, Thiel CL, Chuter R, Collins A, Carollo E, Berg CD, Coleman CN, Abdel-Wahab M, Grover S, Singer L, Mohamad O. Transitioning to Environmentally Sustainable, Climate-Smart Radiation Oncology Care. Int J Radiat Oncol Biol Phys 113(5):915-924, 2022. PMID: 35841919.
31. Terbuch A, Posch F, Bauernhofer T, Jost PJ, Partl R, Stranzl-Lawatsch H, Baciarello G, Fizazi K, Giannatempo P, Verzoni E, Sweeney C, Ravi P, Tran B, Basso U, White J, Vincenzi B, Oing C, Cutuli HJ, Dieckmann KP, Gamulin M, Chovanec M, Fankhauser CD, Heidenreich A, Mohamad O, Thibault C, Fischer S, Gillessen S, International Germ Cell Cancer Collaborative Group. Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy. Int J Radiat Oncol Biol Phys 113(4):825-832, 2022. e-Pub 2022. PMID: 35461737.
32. Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine A, Kim DWN, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, Timmerman RD. SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial. Int J Radiat Oncol Biol Phys 113(2):290-301, 2022. e-Pub 2021. PMID: 34774676.
33. Mohamad O, Feng F. The Time to Evaluate the Impact of PET PSMAs on Management of Prostate Cancer Is Now. Int J Radiat Oncol Biol Phys 113(2):254-255, 2022. PMID: 35569471.
34. Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE, NRG Prostate Cancer AI Consortium, Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit Med 5(1):71, 2022. e-Pub 2022. PMID: 35676445.
35. Ferdinandus J, Fendler WP, Farolfi A, Washington S, Mohamad O, Pampaloni MH, Scott PJH, Rodnick M, Viglianti BL, Eiber M, Herrmann K, Czernin J, Armstrong WR, Calais J, Hope TA, Piert M. PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study. J Nucl Med 63(1):76-80, 2022. e-Pub 2021. PMID: 34620731.
36. Phuong C, Chan JW, Ni L, Wall P, Mohamad O, Wong AC, Hsu IC, Chang AJ. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost. Radiat Oncol 17(1):12, 2022. e-Pub 2022. PMID: 35057827.
37. Alexander J, Beatty A, Mohamad O, Hsu IJ. Relative Incidence of Emergency Department Visits After Treatment for Prostate Cancer With Radiation Therapy or Radical Prostatectomy. Pract Radiat Oncol 12(5):e415-e422, 2022. e-Pub 2022. PMID: 35595216.
38. Lichter KE, Baniel CC, Anderson J, Bhatia R, Frick MA, Thiel CL, Gandhi S, Sarria GR, Bagshaw HP, Petereit D, Chino J, Grover S, Singer L, Hsu IC, Mohamad O. Environmentally sustainable brachytherapy care. Brachytherapy 21(5):712-717, 2022. e-Pub 2022. PMID: 35794032.
39. Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga Y, Courtney K, Cantarel B, Wakeland EK, Fu YX, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clin Cancer Res 27(24):6716-6725, 2021. e-Pub 2021. PMID: 34551906.
40. Chowdhary M, O'Bryant S, Peters GW, Vapiwala N, Mohamad O, Royce TJ. United States Radiation Oncology Fellowship Growth From 2010 to 2020. Int J Radiat Oncol Biol Phys 111(3):622-626, 2021. e-Pub 2021. PMID: 34147580.
41. Chowdhary M, O'Bryant S, Vapiwala N, Mohamad O, Royce TJ. In Reply to Chowdhry. Int J Radiat Oncol Biol Phys 111(4):1093, 2021. PMID: 34655557.
42. van der Wal D, Jhun I, Laklouk I, Nirschl J, Richer L, Rojansky R, Theparee T, Wheeler J, Sander J, Feng F, Mohamad O, Savarese S, Socher R, Esteva A. Biological data annotation via a human-augmenting AI-based labeling system. NPJ Digit Med 4(1):145, 2021. e-Pub 2021. PMID: 34620993.
43. Mohamad O, Feng F. Treating Localized High-Risk Prostate Cancer: Do All Roads Lead to Rome?. Int J Radiat Oncol Biol Phys 110(3):634-635, 2021. PMID: 34089672.
44. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Mohamad O, Cowan JE, Feng FY, Carroll PR, Trock BJ, Partin AW, D'Amico AV. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol 39(20):2284-2293, 2021. e-Pub 2021. PMID: 34086480.
45. Margulis V, Freifeld Y, Pop LM, Manna S, Kapur P, Pedrosa I, Christie A, Mohamad O, Mannala S, Singla N, Wait M, Bagrodia A, Woldu SL, Gahan J, Brugarolas J, Timmerman R, Hannan R. Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial. Int J Radiat Oncol Biol Phys 110(4):1135-1142, 2021. e-Pub 2021. PMID: 33549705.
46. Rodin D, Tawk B, Mohamad O, Grover S, Moraes FY, Yap ML, Zubizarreta E, Lievens Y. Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey. Radiother Oncol 157:32-39, 2021. e-Pub 2021. PMID: 33453312.
47. Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, Morgan TM, Weiner AB, Mohamad O, Carroll PR, Cooperberg MR, Karnes RJ, Nguyen PL, Michalski JM, Tward JD, Feng FY, Schaeffer EM, Spratt DE. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol 79(3):374-383, 2021. e-Pub 2020. PMID: 33293078.
48. Mohamad O, Roach M. Radiation Delay Is Okay, but Where Is the Evidence?. JAMA Oncol 7(3):463-464, 2021. PMID: 33443566.
49. Levin-Epstein RG, Jiang NY, Wang X, Upadhyaya SK, Collins SP, Suy S, Aghdam N, Mantz C, Katz AJ, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas N, Bagshaw H, Buyyounouski MK, Cao M, Agazaryan N, Dang A, Yuan Y, Kupelian PA, Zaorsky NG, Spratt DE, Mohamad O, Feng FY, Mahal BA, Boutros PC, Kishan AU, Juarez J, Shabsovich D, Jiang T, Kahlon S, Patel A, Patel J, Nickols NG, Steinberg ML, Fuller DB, Kishan AU. Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. Radiother Oncol 154:207-213, 2021. e-Pub 2020. PMID: 33035622.
50. Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R. Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma. Adv Radiat Oncol 6(5):100692, 2021. e-Pub 2021. PMID: 34646963.
51. Mohamad O, Roach M. Delaying Dilemmas: Coronavirus Complications Impacting the Management of Prostate Cancer. Int J Radiat Oncol Biol Phys 108(2):337, 2020. PMID: 32890501.
52. Rahimi A, Mohamad O, Albuquerque K, Kim DWN, Chen D, Thomas K, Wooldridge R, Rivers A, Leitch M, Rao R, Haley B, Ahn C, Garwood D, Spangler A. Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial. Support Care Cancer 28(3):1481-1489, 2020. e-Pub 2019. PMID: 31273506.
53. Lin MH, Yang M, Dougherty J, Tasson A, Zhang Y, Mohamad O, Dan T, Yan Y, Gu X, Timmerman R, Laack N, Beltran C. Radiation Therapy for Pediatric Brain Tumors using Robotic Radiation Delivery System and Intensity Modulated Proton Therapy. Pract Radiat Oncol 10(3):e173-e182, 2020. e-Pub 2019. PMID: 31542454.
54. Mohamad O, Wardak Z, Bowers DC, Le AH, Dan T, Abdulrahman R, Gargan L, Klesse L, Weprin B, Swift D, Price A, Ding C, Stojadinovic S, Sklar F, Braga B, Timmerman R. Margin-Free Fractionated Stereotactic Radiation Therapy for Pediatric Brain Tumors. Pract Radiat Oncol 10(6):e485-e494, 2020. e-Pub 2020. PMID: 32428764.
55. Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I, Singla N, Hammers H, Courtney K, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R. Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. Int J Radiat Oncol Biol Phys 105(2):367-375, 2019. e-Pub 2019. PMID: 31377159.
56. Fadel HA, El Ahmadieh TY, Plitt AR, Neeley OJ, Johnson Z, Aoun SG, Mohamad O, Timmerman R, Weprin BE. Oculomotor Schwannomas: A Systematic Review and Report of Two Pediatric Cases Treated with Fractionated Cyberknife Stereotactic Radiotherapy. World Neurosurg 129:487-496, 2019. e-Pub 2019. PMID: 31125775.
57. Doke K, Mohamad O, Royce TJ, Meyer J, Chen AM. Fellowship Training Programs in Radiation Oncology: A Snapshot From 2005 to 2017. Int J Radiat Oncol Biol Phys 104(4):765-772, 2019. e-Pub 2019. PMID: 30885774.
58. Mohamad O, Tabuchi T, Morishima T, Makishima H, Miyashiro I, Tsuji H. Key considerations when reviewing subsequent primary cancers following radiotherapy - Authors' reply. Lancet Oncol 20(6):e292, 2019. PMID: 31162099.
59. Mohamad O, Tabuchi T, Nitta Y, Nomoto A, Sato A, Kasuya G, Makishima H, Choy H, Yamada S, Morishima T, Tsuji H, Miyashiro I, Kamada T. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study. Lancet Oncol 20(5):674-685, 2019. e-Pub 2019. PMID: 30885458.
60. Makishima H, Yasuda S, Isozaki Y, Kasuya G, Okada N, Miyazaki M, Mohamad O, Matsufuji N, Yamada S, Tsuji H, Kamada T, Liver Cancer Working Group. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study. Cancer Sci 110(1):303-309, 2019. e-Pub 2018. PMID: 30417485.
61. Mohamad O, Doke K, Marcrom S, Chen AM, Royce TJ, Meyer JJ. A Fellow's Fate: Employment Outcomes of Radiation Oncology Fellowship Graduates. Int J Radiat Oncol Biol Phys 102(1):16-17, 2018. e-Pub 2018. PMID: 30102192.
62. Mohamad O, Yamada S, Durante M. Clinical Indications for Carbon Ion Radiotherapy. Clin Oncol (R Coll Radiol) 30(5):317-329, 2018. PMID: 29402598.
63. Mohamad O, Imai R, Kamada T, Nitta Y, Araki N, Working Group for Bone and Soft Tissue Sarcoma. Carbon ion radiotherapy for inoperable pediatric osteosarcoma. Oncotarget 9(33):22976-22985, 2018. e-Pub 2018. PMID: 29796166.
64. Mohamad O, Makishima H, Kamada T. Evolution of Carbon Ion Radiotherapy at the National Institute of Radiological Sciences in Japan. Cancers (Basel) 10(3), 2018. e-Pub 2018. PMID: 29509684.
65. Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, Hammers H, Choy H, Timmerman R, Brugarolas J, Hannan R. Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy. Oncoimmunology 7(7):e1440168, 2018. e-Pub 2018. PMID: 29900043.
66. Mkanna A, Mohamad O, Ramia P, Thebian R, Makki M, Tamim H, Jalbout W, Youssef B, Eid T, Geara F, Shahine B, Zeidan YH. Predictors of Cardiac Sparing in Deep Inspiration Breath-Hold for Patients With Left Sided Breast Cancer. Front Oncol 8:564, 2018. e-Pub 2018. PMID: 30538954.
67. Mohamad O, Meyer JJ. Recent Trends in Radiation Oncology Fellowship Training in the United States. Int J Radiat Oncol Biol Phys 99(3):539-540, 2017. e-Pub 2017. PMID: 29280447.
68. Wei L, Wei ZZ, Jiang MQ, Mohamad O, Yu SP. Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. Prog Neurobiol 157:49-78, 2017. e-Pub 2017. PMID: 28322920.
69. Mohamad O, Sishc BJ, Saha J, Pompos A, Rahimi A, Story MD, Davis AJ, Kim DWN. Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair. Cancers (Basel) 9(6), 2017. e-Pub 2017. PMID: 28598362.
70. Song M, Yu SP, Mohamad O, Cao W, Wei ZZ, Gu X, Jiang MQ, Wei L. Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice. Neurobiol Dis 98:9-24, 2017. e-Pub 2016. PMID: 27884724.
71. Mohamad O, Shiao J, Zhao B, Roach K, Ramirez E, Vo DT, Thomas K, Gu X, Spangler A, Albuquerque K, Rahimi A. Deep inspiration breathhold for left-sided breast cancer patients with unfavorable cardiac anatomy requiring internal mammary nodal irradiation. Pract Radiat Oncol 7(6):e361-e367, 2017. e-Pub 2017. PMID: 28666899.
72. Benyamini P, Lopez S, Cooper M, Mohamad O, Maldini G. Congenital Mesenteric Defect: An Uncommon Cause of Bowel Obstruction. Hawaii J Med Public Health 75(2):46-7, 2016. PMID: 26918208.
73. Mohamad O, McFarlane M, Rahimi A. Absence of physiologic breast response to pregnancy and lactation after radiation therapy. Pract Radiat Oncol 6(2):e25-6, 2016. e-Pub 2015. PMID: 26553113.
74. Chen D, Song M, Mohamad O, Yu SP. Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells. BMC Cancer 14:716, 2014. e-Pub 2014. PMID: 25255962.
75. Wei S, Sun J, Li J, Wang L, Hall CL, Dix TA, Mohamad O, Wei L, Yu SP. Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice. Neuroscience 252:489-500, 2013. e-Pub 2013. PMID: 23912033.
76. Drury-Stewart D, Song M, Mohamad O, Guo Y, Gu X, Chen D, Wei L. Highly efficient differentiation of neural precursors from human embryonic stem cells and benefits of transplantation after ischemic stroke in mice. Stem Cell Res Ther 4(4):93, 2013. e-Pub 2013. PMID: 23928330.
77. Song M, Mohamad O, Chen D, Yu SP. Coordinated development of voltage-gated Na+ and K+ currents regulates functional maturation of forebrain neurons derived from human induced pluripotent stem cells. Stem Cells Dev 22(10):1551-63, 2013. e-Pub 2013. PMID: 23259973.
78. Mohamad O, Song M, Wei L, Yu SP. Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice. J Physiol 591(1):149-68, 2013. e-Pub 2012. PMID: 23006484.
79. Song M, Mohamad O, Gu X, Wei L, Yu SP. Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. Cell Transplant 22(11):2001-15, 2013. e-Pub 2012. PMID: 23069268.
80. Mohamad O, Drury-Stewart D, Song M, Faulkner B, Chen D, Yu SP, Wei L. Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice. PLoS One 8(5):e64160, 2013. e-Pub 2013. PMID: 23717557.
81. Mohamad O, Yu SP, Chen D, Ogle M, Song M, Wei L. Efficient neuronal differentiation of mouse ES and iPS cells using a rotary cell culture protocol. Differentiation 86(4-5):149-58, 2013. e-Pub 2014. PMID: 24480155.
82. Majumder A, Banerjee S, Harrill JA, Machacek DW, Mohamad O, Bacanamwo M, Mundy WR, Wei L, Dhara SK, Stice SL. Neurotrophic effects of leukemia inhibitory factor on neural cells derived from human embryonic stem cells. Stem Cells 30(11):2387-99, 2012. PMID: 22899336.
83. Choi KE, Hall CL, Sun JM, Wei L, Mohamad O, Dix TA, Yu SP. A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice. FASEB J 26(7):2799-810, 2012. e-Pub 2012. PMID: 22459147.
84. Li J, Yu S, Lu Z, Mohamad O, Wei L. N-methyl-D-aspartate receptor subtype 3A promotes apoptosis in developing mouse brain exposed to hyperoxia. Neural Regen Res 7(4):273-7, 2012. PMID: 25806068.
85. Mohamad O, Chen D, Zhang L, Hofmann C, Wei L, Yu SP. Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats. Mol Pain 7:51, 2011. e-Pub 2011. PMID: 21777449.
86. Drury-Stewart D, Song M, Mohamad O, Yu SP, Wei L. Small molecule promoted feeder free and adherent differentiation of functional neurons from human embryonic and induced pluripotent stem cells. J Stem Cells 6(1):1-7, 2011. PMID: 22997841.
87. Li Y, Yu SP, Mohamad O, Genetta T, Wei L. Sublethal transient global ischemia stimulates migration of neuroblasts and neurogenesis in mice. Transl Stroke Res 1(3):184-96, 2010. PMID: 21792374.